These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2142230)

  • 1. Proceedings of the Toremifene Symposium. Satellite symposium held at the UICC World Cancer Congress. Budapest, Hungary, 1986.
    J Steroid Biochem; 1990 Jun; 36(3):187-262. PubMed ID: 2142230
    [No Abstract]   [Full Text] [Related]  

  • 2. The significance of estrogen receptors in tamoxifen and toremifene therapy.
    Valavaara R; Kangas L
    Ann Clin Res; 1988; 20(5):380-8. PubMed ID: 2975479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The results of a comparative clinical study of the antiestrogenic preparations toremifene and tamoxifen in locally advanced and disseminated breast cancer].
    Konstantinova MM; Gershanovich MA
    Vopr Onkol; 1990; 36(10):1182-6. PubMed ID: 2147527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon alfa-2a in cancer therapy. Proceedings of an official satellite symposium to the 14 International UICC Cancer Congress. Budapest, Hungary, 22 August 1986.
    Int J Cancer Suppl; 1987; 1():1-45. PubMed ID: 3476472
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic advantages of droloxifene, a new antiestrogen, in breast cancer. Proceedings of a satellite symposium held during the 15th International Cancer Congress. Hamburg, F.R.G., August 18, 1990.
    Am J Clin Oncol; 1991; 14 Suppl 2():S1-63. PubMed ID: 1683742
    [No Abstract]   [Full Text] [Related]  

  • 6. Current status of toremifene, a new antiestrogenic agent for the treatment of breast cancer. A symposium. San Antonio, TX, USA, December 7, 1989.
    Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S1-54. PubMed ID: 1980832
    [No Abstract]   [Full Text] [Related]  

  • 7. Additive and synergistic effects of a novel antiestrogen, toremifene (Fc-1157a), and human interferons on estrogen responsive MCF-7 cells in vitro.
    Kangas L; Nieminen AL; Cantell K
    Med Biol; 1985; 63(4):187-90. PubMed ID: 2419713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
    Robinson SP; Jordan VC
    Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiestrogen therapy for breast cancer: current strategies and future prospects.
    Jordan VC; Tormey DC
    Cancer Treat Res; 1988; 39():97-110. PubMed ID: 2908611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of different combinations of tamoxifen and toremifene on estrogen receptor-positive breast cancer cell lines.
    Coradini D; Biffi A; Cappelletti V; Di Fronzo G
    Cancer Detect Prev; 1995; 19(4):348-54. PubMed ID: 7553677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of MNU-induced mammary tumorigenesis by hormone response modifiers: toremifene, RU 16117, tamoxifen, aminoglutethimide and progesterone.
    Moon RC; Steele VE; Kelloff GJ; Thomas CF; Detrisac CJ; Mehta RG; Lubet RA
    Anticancer Res; 1994; 14(3A):889-93. PubMed ID: 8074489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiestrogens: mechanism of action and clinical applications].
    Barrón-González A; Arias-Martínez J; Castro-Romero I
    Salud Publica Mex; 2001; 43(6):577-84. PubMed ID: 11816234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of toremifene.
    Anttila M; Valavaara R; Kivinen S; Mäenpää J
    J Steroid Biochem; 1990 Jun; 36(3):249-52. PubMed ID: 2142247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New treatment modalities in prostatic cancer: LHRH superagonists. Symposium held during the World Congress of Oncology. Budapest, Hungary, August 26, 1986.
    Am J Clin Oncol; 1988; 11 Suppl 1():S1-46. PubMed ID: 3133942
    [No Abstract]   [Full Text] [Related]  

  • 15. The oestrogen antagonists, tamoxifen and FC-1157a, display oestrogen like effects on human lymphocyte functions in vitro.
    Paavonen T; Andersson LC
    Clin Exp Immunol; 1985 Aug; 61(2):467-74. PubMed ID: 2931228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifene.
    Tiitinen A; Nikander E; Hietanen P; Metsä-Heikkilä M; Ylikorkala O
    Maturitas; 2004 Jul; 48(3):321-7. PubMed ID: 15207898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic method for the determination of toremifene and its major human metabolites.
    Webster LK; Crinis NA; Stokes KH; Bishop JF
    J Chromatogr; 1991 Apr; 565(1-2):482-7. PubMed ID: 1831461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hypothalamus: selected topics. Satellite symposium, Second World Congress of Neuroscience. Budapest, Hungary, August 12-14, 1987. Proceedings.
    Brain Res Bull; 1988 Jun; 20(6):655-902. PubMed ID: 3409050
    [No Abstract]   [Full Text] [Related]  

  • 19. Antioestrogen therapy of pure mesenchymal tumour.
    Wilson AJ; Baum M; Singh L; Kangas L
    Lancet; 1987 Feb; 1(8531):508. PubMed ID: 2881066
    [No Abstract]   [Full Text] [Related]  

  • 20. Minor labial salivary glands. Proceedings of a satellite symposium to the XVth Jubilee Arkovy Congress of Hungarian Dentists. Budapest, Hungary, August 28, 1998.
    Arch Oral Biol; 1999 May; 44 Suppl 1():S1-71. PubMed ID: 10475902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.